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The accumulation of protein aggregates is involved in the onset of many neurodegenerative
diseases. Aggrephagy is a selective type of autophagy that counteracts neurodegeneration by
degrading such aggregates. In this study, we found that LC3C cooperates with lysosomal
TECPR1 to promote the degradation of disease-related protein aggregates in neural stem
cells. The N-terminal WD-repeat domain of TECPR1 selectively binds LC3C which decorates
matured autophagosomes. The interaction of LC3C and TECPR1 promotes the recruitment of
autophagosomes to lysosomes for degradation. Augmented expression of TECPR1 in neural
stem cells reduces the number of protein aggregates by promoting their autophagic clear-
ance, whereas knockdown of LC3C inhibits aggrephagy. The PH domain of TECPR1 selectively
interacts with PtdIns(4)P to target TECPR1 to PtdIns(4)P containing lysosomes. Exchanging
the PH against a tandem-FYVE domain targets TECPR1 ectopically to endosomes. This leads
to an accumulation of LC3C autophagosomes at endosomes and prevents their delivery to
lysosomes.
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Macroautophagy (autophagy in the following) is a highlyconserved cellular recycling pathway that sequesterscytoplasmic material and delivers it to lysosomes for
degradation1,2. A unique Ub-like conjugation system promotes
the conjugation of six human autophagy related 8 proteins
(hATG8s) to the lipid phosphatidylethanolamine within autop-
hagic membranes3,4. These hATG8s are structurally related to
Ub5. The family members LC3A, LC3B and LC3C are coordi-
nating the expansion of phagophores (also called isolation
membranes), whereas GABARAP, GABARAPL1 and -L2 mostly
regulate later steps in autophagy6–8. Their conjugation requires
the sequential action of E1-like ATG7, E2-like ATG3 and E3-like
ATG12–ATG5–ATG16L1 enzymes3,9. Interestingly,
ATG12–ATG5 does not only interact with ATG16L1 to promote
phagophore expansion, it also binds TECPR1 (Tectonin beta-
propeller repeat-containing protein) through a common ATG5-
interacting motif (AIR)10.
TECPR1 possesses two WD-repeat domains (TR), two dys-
ferlin domains, an unstructured region and a PH domain11. The
latter binds phosphatidylinositol-3-phosphate (PtdIns(3)P),
which is present in phagophores and autophagosomes12,13.
TECPR1 localizes to lysosomal membranes and depletion of
TECPR1 leads to an accumulation of p62 and LC3. Furthermore,
TECPR1 expression is downregulated in neurons of patients
suffering from TDP-43 proteinopathies including amyotrophic
lateral sclerosis and frontotemporal dementia14,15. This suggests
that the function of TECPR1 in late steps of autophagy promotes
clearance of protein aggregates12,16. The molecular function of
TECPR1 during late steps of autophagy remains, however,
elusive.
Here we demonstrate that deletion of TECPR1 leads to a
selective accumulation of LC3C-positive autophagosomes that
colocalize with Ub, the selective autophagy receptor p62 and the
late autophagic marker STX17. TECPR1 possesses a LIR motif
that binds all hATG8s and an N-terminal beta-propeller (TR1)
domain that selectively interacts with LC3C. Moreover, TECPR1
binds PtdIns(4)P in vitro and in vivo. Targeting TECPR1 ecto-
pically to PtdIns(3)P-positive membranes impairs trafficking and
degradation of LC3C autophagosomes. Strikingly, overexpression
of TECPR1 in neural stem cells (NSCs) diminishes the accumu-
lation of neurotoxic protein aggregates such as Huntingtin (Htt)
in an autophagy-dependent manner, whereas depletion of LC3C
augments aggregation of proteins. Our results thus show that the
cooperation of LC3C and TECPR1 promotes clearance of protein
aggregates in NSCs by selective autophagy.
Results
TECPR1 binds LC3C selectively. Previous studies suggested that
the lysosomal protein TECPR1 coordinates final steps in autop-
hagy by promoting the fusion of autophagosomes with lyso-
somes12. To reveal whether TECPR1 selectively interacts with
hATG8 members to promote the fusion of autophagosomes with
lysosomes, we applied a proximity-dependent biotin identifica-
tion (BioID) approach17. We therefore co-expressed HA-tagged
hATG8s with BioID-TECPR1 and analyzed biotinylation of
hATG8s in cell lysates. Interestingly, LC3C was strongly bioti-
nylated, whereas no significant biotinylation of the other hATG8s
was observed (Fig. 1a and Supplementary Fig. 1a). We next tested
whether TECPR1 interacts with LC3C by performing co-
immunoprecipitation (co-IP) experiments using GFP-TECPR1
or GFP as bait. We found that TECPR1 selectively interacts with
HA-LC3C, whereas no significant binding of other hATG8s was
detected (Fig. 1b). We next systematically compared the number
of GFP-hATG8 puncta in wild-type and TECPR1-knockout(KO)
cells (Supplementary Table 1). Interestingly, we observed a
significant accumulation of LC3C puncta in TECPR1KO cells
(Fig. 1c and Supplementary Fig. 1b, c). We concluded from these
experiments that the selective interaction of TECPR1 with LC3C
promotes the lysosomal degradation of LC3C vesicles.
To prove this hypothesis, we tested whether TECPR1
colocalizes with LC3C at lysosomes. Consistent with a previous
study12, we found that GFP-TECPR1 puncta colocalized with the
late endosomal/lysosomal markers Rab7 and LAMP2 and with
the recycling endosomal marker Rab11A, but not with the early
endosomal marker EEA1 (Supplementary Fig. 1d, e). Moreover,
TECPR1 was identified on autolysosomes in electron micro-
graphs using correlative light electron microscopy (CLEM)
(Supplementary Fig. 1e). A second population of TECPR1 was
found on smaller vesicles with apparent diameters of ~200 nm
(Supplementary Fig. 1f). We next investigated whether TECPR1
and LC3C colocalize in vivo by coexpressing GFP-TECPR1 with
RFP-LC3C. Consistent with our BioID experiment, a strong
colocalization of both proteins was observed (Fig. 1d). Finally, we
performed CLEM of RFP-LC3C and GFP-TECPR1-positive
puncta and observed that electron-dense LC3C-positive vesicles
are in immediate vicinity of TECPR1-positive autolysosomes
(Supplementary Fig. 1g). Collectively, our results thus suggest that
TECPR1 selectivity interacts with LC3C to facilitate the lysosomal
degradation of LC3C vesicles.
A previous study reported that TECPR1 possesses an ATG5-
interacting region (AIR)12 that promotes the formation of a
lysosomal ATG12–ATG5–TECPR1 complex. To test whether
TECPR1 cooperates with ATG12–ATG5 to recruit LC3C, we
deleted the AIR motif in TECPR1 and investigated the
colocalization of the corresponding TECPR1ΔAIR mutant with
LC3C in TECPR1KO cells. We found that GFP-TECPR1ΔAIR still
strongly colocalized with LC3C (Fig. 1d), demonstrating that
TECPR1 recruits LC3C independently of ATG12–ATG5.
TECPR1 possesses an LC3-interacting motif. The direct and
selective interaction of TECPR1 and LC3C in vivo suggests that
TECPR1 possesses a distinct LC3C binding site. To identify this
site, we first expressed TR1 and TR2 independently in TECPR1KO
cells and investigated their localization and their capacity to
recruit LC3C. The C-terminal TR2 domain was mostly dis-
tributed in the cytosol of TECPR1KO cells (Fig. 2a). By contrast,
TR1 was localizing to Rab7- and LAMP2-positive structures
(Fig. 2b). Furthermore, TR1 colocalized with LC3C to a similar
degree as TECPR1 (Supplementary Fig. 2a, b). We concluded that
the TR1 domain targets TECPR1 to lysosomes and possesses an
LC3C selective binding motif.
Many proteins that bind hATG8s contain a conserved peptide
motif, termed LC3-interacting region (LIR)18. By analyzing the
sequence of TR1, we identified the potential LIR W175AKI178. To
test whether this motif selectively interacts with LC3C, we
conjugated hATG8s to small unilamellar vesicles (SUVs) and
performed cofloatation assays using a peptide that contained the
LIR. We recovered this peptide from all fractions that contained
hATG8-SUVs, but not from those that lacked hATG8s (Fig. 2c).
This demonstrates that although the LIR W175AKI178 interacts
with hATG8s, it is promiscuous and does not selectively
recognize LC3C. To confirm the specificity of the interaction,
we mutated residues W175 and I178 to alanine (A175AKA178) and
repeated floatation experiments. The amount of the A175AKA178
peptide that was recovered from membrane fractions was strongly
reduced (Fig. 2c), showing that the interaction of the LIR
W175AKI178 with hATG8s is specific.
In order to characterize the functional importance of the
identified LIR in vivo, we applied a BioID assay by coexpressing
MycBioID-TECPR1wt or the corresponding LIR mutant
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(MycBioID-TECPR1W175A/I178A) with HA-LC3C in TECPR1KO
cells. We found that HA-LC3C was strongly biotinylated in cells
expressing MycBioID-TECPR1wt but only weakly if MycBioID-
TECPR1W175A/I178A was expressed (Fig. 2d). Moreover, the weak
yet detectable biotinylation of LC3B was further decreased in cells
expressing the LIR mutant MycBioID-TECPR1W175A/I178A.
Finally, co-immunoprecipitation of LC3B or LC3C with
TECPR1wt or TECPR1W175A/I178A confirmed that the LIR motif
is important but not essential for LC3C binding (Supplementary
Fig. 2c). Our data thus show that the selectivity of TECPR1
towards LC3C requires a cooperation of its promiscuous LIR with
other regions in TECPR1, most likely localized within the TR1
domain.
TECPR1 recruits LC3C vesicles to lysosomes. The proximal
subcellular localization of LC3C and TECPR1 and their direct
interaction raise the question whether LC3C and TECPR1
interact in cis at the same or in trans at two distinct membranes.
To address this question, we co-expressed RFP-TECPR1 and
GFP-LC3C in HeLa cells and analyzed their colocalization with
the lysosomal marker LAMP2 or with the late autophagic marker
Syntaxin 17 (STX17). Interestingly, TECPR1 mainly colocalized
with LAMP2, whereas a strong colocalization of LC3C with
STX17 but not with LAMP2 was observed (Fig. 3a and Supple-
mentary Fig. 3a). Of note, many STX17-positive LC3C puncta
were in close proximity to LAMP2-positive TECPR1 structures.
Since STX17 is only present at completed and fully sealed
autophagosomes8, our results suggest that LC3C vesicles corre-
spond to completed autophagosomes.
To further characterize this apparent juxtaposition, we
analyzed the colocalization of TECPR1 and LC3C with LAMP2
and STX17 by structured-illumination microscopy. We indeed
observed that GFP-TECPR1 and LAMP2 colocalized at big
structures, whereas GFP-LC3C was present on small puncta
proximal to RFP-TECPR1 (Fig. 3b and Supplementary Movie 1).
Moreover, expression of GFP-TECPR1 and immunostaining for
endogenous LC3 family proteins revealed a similar pattern. Small
LC3-positive puncta were in juxtaposition with GFP-TECPR1
and LAMP2-positive structures (Supplementary Fig. 3b).
To investigate whether membrane bound TECPR1 indeed
recruits LC3C vesicles, we reconstituted the system with purified
proteins on model membranes. In a first step, we conjugated
Alexa488-labeled LC3C to SUVs using the purified human Ub-
like conjugation system (Supplementary Fig. 3c). These SUVs
represent LC3C vesicles that were observed in the vicinity of

















































































































































































Fig. 1 TECPR1 binds LC3C independently of ATG12–ATG5. a BioID assay of TECPR1KO cells cotransfected with MycBioID-TECPR1 and HA-tagged
hATG8s. Corresponding cell lysates were precipitated using streptavidin beads and samples were immunoblotted with the indicated antibodies. GAB=
GABARAP. b Immunoprecipitation (IP) of GFP-TECPR1 or GFP and co-IP of HA-LC3C from lysates of cells expressing HA-LC3C and GFP-TECPR1 or GFP.
Actin served as loading control. Western blots of lysates and co-IPs as indicated. c The number of GFP-hATG8 puncta was counted in starved wild-type
(wt) or TECPR1KO cells as well as in TECPR1KO cells transfected with RFP-TECPR1 (n= 47 cells pooled from three independent experiments). Box plots
represent the first (25%) and third (75%) quartiles, respectively. The center line represents the median, whiskers the standard deviation and minima and
maxima are available from the Source Data file. P-values were calculated using a two-tailed Student’s t-test (**P < 0.01, ***P < 0.001). d Confocal images of
TECPR1KO cells coexpressing GFP-TECPR1 or GFP-TECPR1ΔAIR and RFP-LC3C. Both TECPR1 and TECPR1ΔAIR colocalized with LC3C. Scale bars, 10 µm.
Source data are provided as a Source Data file.
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TECPR1 in order to mimic lysosomal TECPR1-positive compart-
ments. After coincubation of both membrane populations, we
indeed observed a pronounced clustering of LC3C-SUVs at
TECPR1-positive GUVs. However, in the absence of TECPR1,
GUVs failed to recruit LC3C-SUVs (Supplementary Fig. 3d). Our
experiments thus demonstrate that TECPR1 recruits LC3C
vesicles in vitro.
We next aimed to characterize the dynamic interaction of
LC3C and TECPR1 compartments in time and space by following
trafficking of LC3C to TECPR1 in living cells. One fraction of
LC3C puncta (16 ± 2%) was tethered to TECPR1 structures (>1.0
µm in diameter), whereas the second population was in transient
contact (Fig. 3c and Supplementary Movie 2). We next tested,
whether TECPR1 compartments correspond to acidified lyso-
somes using lysotracker deep red. We found that 25% of
lysotracker positive structures colocalize with TECPR1. Theses
lysosomes appeared to be larger (>1 µm) and less mobile than
structures that did not colocalize with TECPR1. Interestingly, we
occasionally observed ring-like GFP-TECPR1 structures that
contained dot-like lysotracker staining, which is consistent with a
mainly (auto)lysosomal localization of TECPR1 (Supplementary
Fig. 3e and Movie 3). We next followed trafficking of LC3C
vesicles to acidic compartments in lysotracker-treated cells that
expressed GFP-LC3C. We again observed two populations of
LC3C puncta. One fraction of puncta with diameters >0.5 µm
colocalized with immobile and large (<1 µm) lysotracker
structures. However, the majority of LC3C puncta (85%) was
smaller and interacted with acidified compartments transiently
(Supplementary Fig. 3f and Movie 4). Our data thus show that
LC3C puncta are either tethered to or in transient contact with
TECPR1 compartments.
TECPR1 selectively binds PtdIns(4)P. TECPR1 possesses in
addition to TR1 a lipid binding PH domain. To reveal potential
synergistic effects of both domains in targeting TECPR1 to
lysosomes, we tested the cellular localization of a mutant in which



























































































































Fig. 2 TECPR1 possesses an LC3-interacting motif. a Colocalization of immunostained LAMP2 and HA-LC3C with GFP-tagged TR2 in starved TECPR1KO
cells. Scale bars, 10 µm. b Colocalization of immunostained Rab7, LAMP2 and HA-LC3C with GFP-tagged TR1 in starved TECPR1KO cells. Scale bars, 10 µm.
c Floatation assay of small unilamellar vesicles to which the indicated hATG8 variant was conjugated with a peptide (TECPR1158–187) that contained the
W175xxI178 motif or its corresponding A175xxA178 mutant (LIR mut). The membrane-free protein fractions (P) and the floating liposome fractions (L) were
collected and analyzed by SDS-PAGE. d BioID assay of TECPR1KO cells transfected with the empty vector pLPCX (mock), pLPCX-MycBioID-TECPR1
(TECPR1) or pLPCX-MycBioID-TECPR1W175A/I178A (TECPR1LIR), and cotransfected with either HA-LC3C or HA-LC3B. Corresponding cell lysates were
precipitated using streptavidin beads and samples were immunoblotted with the indicated antibodies. Source data are provided as a Source Data file.
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finding that TR1 is sufficient for lysosomal targeting, we found
that GFP-TECPR1ΔPH still colocalized with the lysosomal marker
LAMP2. Moreover, GFP-TECPR1ΔPH still recruited LC3C
puncta, indicating that the PH domain and TR1 have non-
redundant and independent functions (Fig. 4a). We next tested,
whether the PH domain targets TECPR1 to PtdIns(3)P enriched
membranes using the PtdIns(3)P-sensor RFP-2xFYVE. Neither
TECPR1ΔPH nor TECPR1WT colocalized with RFP-2xFYVE
(Supplementary Fig. 4a). We concluded that the PH domain
does not bind PtdIns(3)P in vivo.
We next investigated the binding specificity of TECPR1 to
PtdIns(3)P and PtdIns(3,5)P2 in vitro by incubating purified
TECPR1 with PtdInsP-containing GUVs. No recruitment of
TECPR1 to such GUVs was observed (Supplementary Fig. 4b)
confirming our in vivo data that TECPR1 does not interact with
PtdIns(3)P or PtdIns(3,5)P2.
Many PH domains are known to selectively interact with
PtdIns(4,5)P219. We thus incubated purified TECPR1 with GUVs
that contained PtdIns(4,5)P2. Again, no interaction of TECPR1
with such GUVs was observed (Fig. 4b). Moreover, GFP-TECPR1
and GFP-TECPR1ΔPH did not colocalize with PtdIns(4,5)P2 in
HeLa cells (Supplementary Fig. 4c). We continued to search for
ligands of the PH domain by exploring binding of PtdIns(4)P,
which is known to coordinate the fusion of autophagosomes with
lysosomes20, to TECPR1. Interestingly, recombinant
TECPR1 strongly and selectively interacted with PtdIns(4)P
containing GUVs (Fig. 4b). Moreover, TECPR1 was recruited to
PtdIns(4)P-positive membranes in vivo (Fig. 4c), whereas the
colocalization of TECPR1ΔPH with PtdIns(4)P was significantly
reduced (Fig. 4c and Supplementary Fig. 4d). Furthermore,
structured-illumination microscopy revealed that TECPR1 colo-
calized with PtdIns(4)P at LAMP1-positive structures (Fig. 4d).
This suggests that the PH domain targets TECPR1 to a PtdIns(4)
P containing subpopulation of lysosomes, whereas lysosomal
localization per se depends on the TR1 domain.
To test this idea, we depleted the pool of PtdIns(4)P in HeLa
cells by knocking down the PtdIns(4)-kinase 2 alpha (PI4KIIα)
and/or the PtdIns(5) phosphatase OCRL, both of which are
known regulators of autophagy20,21. Consistent with our
observation that the PH domain is dispensable for lysosomal
localization of TECPR1, neither depletion of PI4KIIα or OCRL,
nor that of both enzymes impacted on the recruitment of
TECPR1 to LAMP2 compartments (Supplementary Fig. 4e). The
few PtdIns(4)P structures that were observed in PI4KIIα knock-
down cells did not colocalize with TECPR1 (Supplementary
Fig. 4f). We next depleted PtdIns(4)P by overexpressing the RFP-
tagged PtdIns(4)-phosphatase Sac2 and investigated whether
TECPR1 still recruits LC3C. We observed a strong colocalization
of TECPR1, Sac2 and LC3C, demonstrating that binding of
PtdIns(4)P and recruitment of LC3C are independent functions
of TECPR1 (Supplementary Fig. 4g).
In summary, we found that the recruitment of TECPR1 to






















































Fig. 3 TECPR1 recruits LC3C vesicles to lysosomes. a Quantitative analysis of the colocalization of GFP-LC3C and GFP-TECPR1 with immunostained
LAMP2 and STX17 in starved HeLa cells (n= 20 cells pooled from three independent experiments). Data are represented as mean ± SD. b Structured-
illumination microscopy of starved HeLa cells expressing GFP-TECPR1 or RFP-TECPR1 together with GFP-LC3C as indicated. Cells were fixed and
immunostained for LAMP2 or STX17. LC3C puncta are in the immediate vicinity of TECPR1/LAMP2 compartments. Scale bars, 10 µm, insets, 2.5 µm.
c Time-lapse video microscopy of TECPR1KO cells coexpressing RFP-TECPR1 and GFP-LC3C. Confocal images were captured every 10 s and every other
frame is shown. Arrows indicate moving structures that transiently interact. Scale bar, 10 µm, insets, 2.5 µm. See also Supplementary Movies 1, 2, 3 and 4.
Source data are provided as a Source Data file.
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TECPR1 defines the subcellular destination of LC3C autop-
hagosomes. Our data suggest that PtdIns(4)P regulates fusion of
autophagosomes and lysosomes by targeting TECPR1 to specia-
lized lysosomal compartments. However, PtdIns(4)P is also pre-
sent in autophagic membranes20. To reveal closer insights into
the relationship between recruitment of autophagosomes, their
fusion with lysosomes and PtdIns(4)P, we uncoupled TECPR1
from autophagic and lysosomal PtdIns(4)P pools. We therefore
ectopically targeted TECPR1 to endosomes by exchanging its PH
against the PtdIns(3)P binding tandem-FYVE domain
(TECPR1ΔPH-2xFYVE). We first compared the colocalization of
GFP-TECPR1WT, GFP-TECPR1ΔPH and GFP-TECPR1ΔPH-
2xFYVE with the early endosomal marker EEA1. As expected,
neither GFP-TECPR1WT nor GFP-TECPR1ΔPH colocalized with
EEA1, whereas a strong colocalization of GFP-TECPR1ΔPH-
2xFYVE with EEA1 was observed (Fig. 5a, b). Interestingly, aber-
rant EEA1-positive structures were observed in GFP-
TECPR1ΔPH-2xFYVE-expressing cells, whereas EEA1 formed
many small and dispersed puncta in GFP-TECPR1WT cells.
Furthermore, these EEA1 clusters colocalized with the early
endosomal marker Rab5 and with late endosome/lysosome
markers Rab7 and LAMP2 (Supplementary Fig. 5a). Moreover
CLEM experiments revealed that GFP-TECPR1ΔPH-2xFYVE
colocalized with multivesicular bodies (MVBs, Supplementary
Fig. 5b), suggesting that TECPR1ΔPH-2xFYVE induces the forma-
tion of atypical endosomes. To exclude that endosomal trafficking
or degradation of endocytosed material is perturbed in cells
expressing TECPR1ΔPH-2xFYVE, we next performed epidermal
growth factor receptor (EGFR) degradation assays. No difference
in the decline of EGFR levels was observed in TECPR1KO cells
(Supplementary Fig. 5c) or in cells expressing TECPR1ΔPH or
TECPR1ΔPH-2xFYVE (Supplementary Fig. 5d). This shows that
TECPR1 is dispensable for EGFR degradation and that clustering
of atypical endosomes in TECPR1ΔPH-2xFYVE-expressing cells
does not impair endosomal trafficking.
Many lysosomal tethering factors contribute to the recruitment
of autophagosomes to lysosomes. To determine whether TECPR1
acts independently of these factors, we analyzed the recruitment
of GFP-LC3C puncta to early endosomes in TECPR1KO cells that
expressed RFP-TECPR1WT, -TECPR1ΔPH or -TECPR1ΔPH-
2xFYVE. Small EEA1 puncta that did not colocalize with LC3C
were observed in TECPR1WT or TECPR1ΔPH-expressing cells.
Similar LC3C-negative EEA1 puncta were also present in cells
expressing TECPR1ΔPH-2xFYVE. However, these cells contained a
second population of bigger EEA1 clusters at which LC3C and




















































Fig. 4 TECPR1 selectively binds PtdIns(4)P. a Colocalization of GFP-TECPR1ΔPH with RFP-LC3C or immunostained LAMP2. Scale bars, 10 µm. b Binding of
Alexa488-labeled TECPR1 to GUVs containing indicated PtdInsP. Scale bars, 20 µm. See also Supplementary Fig. 4b. c Colocalization of GFP-TECPR1 or
GFP-TECPR1ΔPH with immunostained PtdIns(4)P in TECPR1KO cells. Scale bars, 10 µm. d Structured-illumination microscopy of TECPR1KO cells expressing
GFP-TECPR1 that were stained for LAMP1 and PtdIns(4)P. Scale bar, 10 µm, insets, 2.5 µm.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16689-5
6 NATURE COMMUNICATIONS |         (2020) 11:2993 | https://doi.org/10.1038/s41467-020-16689-5 | www.nature.com/naturecommunications
Movie 5). This observation demonstrates that TECPR1 recruits
LC3 autophagosomes independently of PtdIns(4)P or of other
lysosomal proteins.
Given that TECPR1 selectively interacts with LC3C, we
predicted that other ATG8s are not rerouted to endosomes. To
test this prediction, we analyzed colocalization of all ATG8s with
EEA1 in TECPR1ΔPH-2xFYVE-expressing cells. We found that
only GFP-LC3C strongly colocalized with TECPR1ΔPH-2xFYVE at
EEA1 clusters, whereas no or very weak colocalization was
observed for other hATG8s (Fig. 5d and Supplementary Fig. 5e).
This confirms that TECPR1 selectively recruits LC3C vesicles.
Our data showed that the LIR motif of TECPR1 is important,
yet not essential for LC3C binding. We therefore tested whether
LC3C vesicles were rerouted to endosomes if the LIR motif in
TECPR1ΔPH-2xFYVE was inactivated in LIR mutants W175A,
I178A and W175A/I178A. We found that these LIR mutants were
still recruited to and induced clustering of EEA1 (Supplementary
Fig. 5f). However, a significantly reduced colocalization of these
mutants with endogenous LC3 was observed (Fig. 5e and
Supplementary Fig. 5f). Thus, the LIR motif of TECPR1 is not
only important for the interaction of TECPR1 with hATG8s
in vitro, it also facilitates the recruitment of LC3 in vivo. Taken
together, we demonstrate here that the localization of TECPR1
defines the intracellular destination of LC3C vesicles indepen-
dently of other co-factors. This suggests that TECPR1 acts
upstream of other lysosomal proteins that have previously been
shown to coordinate autophagosome–lysosome fusion such as the
HOPS complex22,23.
TECPR1 and LC3C coordinate targeting of protein aggregates



















































































































Fig. 5 TECPR1 determines the subcellular destination of LC3C autophagosomes. a Colocalization of GFP-TECPR1, GFP-TECPR1ΔPH or GFP-TECPR1ΔPH-
2xFYVE with immunostained EEA1 in TECPR1KO cells. Scale bars, 10 µm. b Quantification of colocalization as shown in a, n= 20 cells pooled from three
independent experiments. Box plots represent the first (25%) and third (75%) quartiles, respectively. The center line represents the median, whiskers the
standard deviation and minima and maxima are available from the Source Data file. P-values were calculated using a two-tailed Student’s t-test (***P <
0.001). c Confocal images of starved TECPR1KO cells coexpressing GFP-LC3C and either RFP-TECPR1, RFP-TECPR1ΔPH or RFP-TECPR1ΔPH-2xFYVE that were
immunostained for EEA1. Scale bars, 10 µm, insets 2.5 µm. d Quantification of colocalization between GFP-hATG8s and RFP-TECPR1ΔPH-2xFYVE as shown in
Supplementary Fig. 5e. n= 40 cells pooled from three independent experiments. Box plots represent the first (25%) and third (75%) quartiles,
respectively. The center line represents the median, whiskers the standard deviation and minima and maxima are available from the Source Data file. P-
values were calculated using a two-tailed Student’s t-test (***P < 0.001). e Quantification of colocalization between GFP-TECPR1ΔPH-2xFYVE or its LIR
mutants with LC3 as shown in Supplementary Fig. 5f, n= 32 cells pooled from three independent experiments. Box plots represent the first (25%) and third
(75%) quartiles, respectively. The center line represents the median, whiskers the standard deviation and minima and maxima are available from the
Source Data file. P-values were calculated using a two-tailed Student’s t-test (***P < 0.001). See also Supplementary Movie 5. Source data are provided as a
Source Data file.
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LC3C has multiple functions in autophagy24–27. Not surprisingly,
the number of LC3C puncta exceeds by far that of the other
ATG8 homologs (Fig. 1c). In order to characterize the pool of
LC3C autophagosomes that is selectively recognized by TECPR1,
we made use of the ectopic targeted TECPR1ΔPH-2xFYVE con-
struct. We first asked whether TECPR1 recruits LC3C vesicles
that contain a specific type of cargo by determining the coloca-
lization of GFP-LC3C puncta with selective cargo markers in
RFP-TECPR1ΔPH-2xFYVE-expressing cells. The two organellar
markers Hsp60 (mitochondrial chaperonin) and PMP70 (perox-
isomal membrane protein) did not colocalize with LC3C (Sup-
plementary Fig. 6a). However, LC3C strongly colocalized with the
autophagy receptor p62 and with ubiquitin (Ub) (Supplementary
Fig. 6b), both of which are implemented in many types of
selective autophagy. To reveal deeper insights into the nature of
cargo transported by LC3C vesicles, we characterized the ultra-
structure of these vesicles by CLEM. We found that RFP-LC3C
fluorescence colocalized with autophagosomes that contained
electron-dense, amorphous material that resembles protein
aggregates (Fig. 6a). To verify that LC3C is involved in aggre-
phagy, we next selectively increased the number of protein
aggregates by treating HeLa cells with puromycin. We found that
the vast majority of Ub/p62-positive puncta colocalized with
GFP-LC3C (Fig. 6b), arguing that LC3C vesicles are indeed
autophagosomes that contain protein aggregates.
The major function of p62 is to tether cargo to the inner
autophagic membrane through its interaction with hATG8s that
are conjugated to the inner membrane of autophagosomes. This
confines p62 and hATG8s in the lumen of autophagosomes,
which leads to their degradation in lysosomes. Moreover, luminal
hATG8s are inaccessible for lysosomal TECPR1. To reveal the
primary localization of LC3C on autophagosomes, we used the
pH-sensitive RFP-GFP-LC3C reporter. We found that the
majority of LC3C puncta in wild-type as well as TECPR1KO
cells was yellow (Fig. 6c), suggesting that LC3C is mainly
conjugated to the outer autophagic membrane. To confirm our
findings, we next performed proteinase K protection assays of
lysates of GFP-LC3C-expressing cells to determine the fraction of
LC3C that is accessible by the protease (Fig. 6d). We found that
~60% of GFP-LC3C was degraded after 60 min of proteinase K
treatment in the absence, and 90% in the presence of detergent.
This shows that the majority of LC3C is not protected from
proteinase K and thus likely to be conjugated to the cytoplasmic
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Fig. 6 TECPR1 and LC3C coordinate targeting of aggregates to lysosomes. a Correlative light electron micrograph of HeLa cells that expressed RFP-LC3C.
The electron micrograph shows a 70 nm section. RFP-LC3C fluorescence correlated with a double membrane structure that surrounds electron-dense
amorphous material. Scale bar, 200 nm. b Confocal images of puromycin-treated TECPR1KO cells that co-expressed RFP-TECPR1 and GFP-LC3C and that
were immunostained for Ub or p62. Scale bars, 10 µm. c Confocal images of puromycin-treated wild-type (wt) and TECPR1KO cells expressing RFP-GFP-
LC3C. Most structures displayed GFP and RFP fluorescence. Scale bars, 10 µm. d Proteinase K protection assay of GFP-LC3C transfected HeLa cells.
Immunoblotting was performed using an anti-GFP antibody. Lysates were incubated with Proteinase K for indicted times in the absence or presence of
Triton X-100. The chart shows quantification of three independent experiments (mean ± SD). Source data are provided as a Source Data file.
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(~30%) that was protected from proteinase K resides within
autophagosomes, which is consistent with the previously reported
function of LC3C to be a cargo tether.
To consolidate our model that TECPR1 and LC3C cooperate
to promote aggrephagy, we next performed a comprehensive
series of pulse-chase experiments to follow clearance of
puromycin-induced protein aggregates. We first depleted
LC3C from wild-type or TECPR1KO cells by siRNA (Supple-
mentary Fig. 6d) followed by puromycin treatment for 2–4 h
(pulse). We then chased the clearance of protein aggregates in
the presence and absence of the proteasome inhibitor MG132.
We observed that the clearance of protein aggregates was not
impaired in TECPR1KO cells that expressed normal levels of
LC3C. Moreover, additional depletion of LC3C in TECPR1KO
cells induced only a mild accumulation of aggregates
(Supplementary Fig. 6d, e), suggesting that TECPR1 and
LC3C are not essential. To test whether other ATG8 proteins
are involved in this pathway, we next depleted either all
LC3 proteins or all GABARAP proteins in puromycin-treated
wild-type cells, followed by puromycin retrieval. Again, a
moderate delay in protein clearance was observed in cells
lacking LC3s, whereas knockdown of all GABARAP proteins
had a much stronger effect (Supplementary Fig. 6e, f).
This observation is consistent with several other studies
that reported a stronger impairment of autophagy upon
depletion or deletion of GABARAPs compared to that of
LC3s28,29. The greater dependency on GABARAPs was
attributed to their function in autophagosome–lysosomes
fusion. We predicted that depletion of GABARAPs leads to
an accumulation of LC3 puncta. To test this prediction, we
treated TECPR1ΔPH-2xFYVE-expressing cells with siRNAs
against all GABARAPs and investigated clustering of LC3
puncta at EEA1-positive compartments (Supplementary
Fig. 6g). We indeed observed a significantly enhanced
colocalization of LC3, EEA1 and TECPR1ΔPH-2xFYVE (Supple-
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Fig. 7 TECPR1 promotes aggregate clearance in neural cells. a Confocal images of neural stem cells expressing GFP-TECPR1 that were immunostained for
EEA1 and Ubiquitin. The lower panel shows a magnification of the area that is indicated in the upper panel. Scale bar = 10 µm. b Confocal images of NSCs
coexpressing GFP-LC3C and RFP-LC3B, costained for p62 or ubiquitin as indicated. Scale bar = 10 µm. c Confocal images of NSCs that were treated with
siRNAs against ATG8 proteins as indicated and immunostained for ubiquitin. Scale bars, 10 µm. d Quantification of Ub puncta per cells from data
corresponding to representative images as shown in c from cells of randomly chosen field of views (n= 70 cells pooled from four independent
experiments). Box plots represent the first (25%) and third (75%) quartiles, respectively. The center line represents the median, whiskers the standard
deviation and minima and maxima are available from the Source Data file. e Confocal images of NSCs expressing RFP-HttQ97 and GFP-TECPR1 or GFP-
TECPR1ΔPH2xFYVE, immunostained for ubiquitin were treated with the lysosomal inhibitor Bafilomycin A1 (Baf) as indicated. Note that for merged images,
ubiquitin is shown in the blue channel instead of gray. Scale bar = 10 µm. See also Supplementary Movie 6. Source data are provided as a Source Data file.
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dispensable for LC3 puncta formation but required for
lysosomal clearance of protein aggregates.
TECPR1 promotes aggregate clearance in neural cells. The
hallmark of neurodegenerative diseases is the accumulation of
Ub- and p62-positive protein aggregates in neural cells. We
thus tested whether LC3C and TECPR1 are essential for
aggrephagy in neural stem cells that expressed GFP-TECPR1 or
its variant GFP-TECPR1ΔPH-2xFYVE. Consistent with our
findings in HeLa cells, TECPR1WT colocalized with LAMP1,
whereas TECPR1ΔPH-2xFYVE predominantly associated with
EEA1-positive structures in NSCs (Supplementary Fig. 7a, b).
We next analyzed the number and morphology of Ub puncta in
wild-type and GFP-TECPR1-expressing cells. As expected,
small Ub puncta were detected in wild-type NSCs. However,
almost no Ub puncta were observed in NSCs that expressed
GFP-TECPR1 (Fig. 7a), suggesting that TECPR1 promotes
clearance of protein aggregates. Furthermore, TECPR1ΔPH-
2xFYVE transfected NSCs contained fewer but much larger Ub
puncta, most of which colocalized with EEA1 (Supplementary
Fig. 7c and d). Thus, expressing TECPR1ΔPH-2xFYVE in NSCs
induces the formation of aberrant EEA1 structures at which Ub
clusters.
We next investigated whether the observed decline in Ub
puncta upon overexpression of TECPR1WT depends on autop-
hagy using the autophagy-inhibitor Bafilomycin A1 (BafA1). We
found that under these conditions also cells that expressed
TECPR1WT contained Ub puncta (Supplementary Fig. 7e).
Similar effects were not observed in HeLa cells, providing further
evidence that neural cells strongly depend on TECPR1 to
maintain their protein homeostasis. We next treated NSCs with
puromycin to selectively increase the number of protein
aggregates. We found that even under these conditions, GFP-
TECPR1-expressing NSCs were devoid of Ub puncta, whereas Ub
puncta were observed when autophagy was inhibited by BafA1
(Supplementary Fig. 7f, g). Collectively, these results show that
TECPR1 promotes the clearance of protein aggregates in NSCs by
augmenting autophagy.
Our studies in HeLa cells revealed a close collaboration of
LC3C and TECPR1 in aggrephagy. Consistent with this
observation, Ub puncta colocalized with LC3C in puromycin-
treated NSCs and in BafA1-treated NSCs that expressed GFP-
TECPR1 (Supplementary Fig. 7f). Moreover, Ub and LC3C-
positive puncta also colocalized with the autophagy receptor
p62, whereas no significant colocalization with RFP-LC3B
was detected, confirming the selective recruitment of LC3C to
such puncta (Fig. 7b and Supplementary Movie 6). To
confirm that the formation of LC3C puncta was autophagy-
dependent, we next inhibited autophagy by treating NSCs with
the PI3-kinase inhibitor wortmannin. We found that the
number of LC3C puncta was strongly reduced while puncta
formation of TECPR1 was not disturbed (Supplementary
Fig. 7h). Moreover, TECPR1 puncta still colocalized with
lysosomal markers. Wortmannin inhibits not only
autophagy but also endosomal pathways. We thus treated
GFP-TECPR1-expressing NSCs with the selective VPS34
inhibitor SAR405 and investigated colocalization of TECPR1
with LAMP1 and lysotracker. We found that most TECPR1
puncta did not colocalize with both lysosomal markers,
suggesting that the recruitment of TECPR1 to lysosomes
depends on autophagy (Supplementary Fig. 7i). Such an
interdependence between TECPR1 localization and autophagy
is consistent with our observation that TECPR1 preferentially
associates with autolysosomes instead of lysosomes (Supple-
mentary Fig. 1e).
To explore the recruitment of LC3C vesicles by TECPR1 in
more detail, we followed trafficking of LC3C puncta to
TECPR1 structures in puromycin-treated NSCs that co-
expressed RFP-LC3C and GFP-TECPR1 or GFP-TECPR1ΔPH-
2xFYVE. We observed that RFP-positive TECPR1 compartments
fused with several LC3C puncta during the imaging time in cells
expressing GFP-TECPR1 (Supplementary Movies 7 and 8).
Moreover, expression of GFP-TECPR1ΔPH-2xFYVE-induced clus-
tering of LC3C puncta, which did not fuse with TECPR1ΔPH-
2xFYVE structures (Supplementary Movies 9 and 10). Taken
together, we found that TECPR1 is preferentially recruited to
autolysosomes that fuse with several LC3C vesicles.
We next investigated whether fusion of LC3C and TECPR1
compartments correlated with delivery of protein aggregates to
lysosomes using GFP-RFP-p62 as reporter. The confinement of
p62 in the lumen of autophagosomes leads to its delivery to
lysosomes, where the fluorescence of GFP but not that of RFP
is quenched. We found that more than 90% of p62 puncta are
yellow in wild-type NSCs, whereas a significant increase in the
fraction of red p62 puncta was observed in cells expressing
GFP-TECPR1. Moreover, TECPR1ΔPH-2xFYVE transfected cells
contained mostly yellow p62 puncta (Supplementary Fig. 7k).
Taken together, significantly more p62 is delivered to
lysosomes in TECPR1-expressing cells, suggesting that over-
expression of TECPR1 leads to an increased flux of autophagic
cargo in NSCs.
Given that TECPR1 selectively interacts with LC3C, we next
explored the contribution of LC3C to aggrephagy by depleting
either LC3C alone, all three LC3s or all six hATG8s collectively
from NSCs using siRNA. We found that Ub puncta strongly
accumulated in LC3C depleted cells (Fig. 7c, d), whereas no
further increase in the number or size of Ub clusters was observed
in cells depleted for all LC3s. This observation confirms that
LC3A and LC3B are not significantly contributing to aggrephagy.
However, siRNA of all hATG8s together resulted in a stronger
accumulation of Ub puncta (Fig. 7c, d), demonstrating that LC3C
and GABARAPs act independently with LC3C promoting
recruitment of autophagosomes, whereas GABARAPs facilitate
their fusion with lysosomes.
Collectively, our study provides strong evidence that TECPR1
and LC3C promote clearance of protein aggregates in NSCs. This
raises the question whether the pathway is also required to degrade
disease-related protein aggregates in neural cells. To answer this
question, we co-expressed RFP-tagged poly-glutamine Huntingtin
(HttQ97) with TECPR1 or TECPR1ΔPH2xFYVE in NSCs. We found
that cells expressing TECPR1 were devoid of RFP-HttQ97 and Ub
puncta, whereas many puncta were present in non-transfected cells
(Fig. 7e). Moreover, bigger HttQ97 puncta that colocalized with Ub
were detected in TECPR1ΔPH2xFYVE-expressing NSCs. Finally, Htt
aggregates were present in TECPR1 and TECPR1ΔPH2xFYVE-
expressing cells if autophagy was inhibited by BafA1 treatment
(Fig. 7e), demonstrating that the clearance of Htt aggregates occurs
in an autophagy-dependent fashion.
Taken together, our study provides compelling evidence that
TECPR1 and LC3C are key components of a specialized pathway
that promotes aggrephagy in neural cells.
Discussion
Selective autophagy is a pivotal recycling mechanism in eukar-
yotic cells that ensures cellular homeostasis to be maintained. The
selection of cargo, including damaged or superfluous organelles
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but also protein aggregates, is coordinated by a set of autophagy
receptors. The major function of these receptors is to tether cargo
to autophagic membranes by binding hATG8s that are con-
jugated to the inner membrane of autophagosomes25,27,30. A
second pool of hATG8s is conjugated to the outer membrane of
autophagosomes with LC3B being the most abundant and best
characterized family member during starvation-induced
autophagy30.
Here we show that the majority of LC3C structures contain
protein aggregates, which also colocalize with STX17. Moreover,
we found that most of LC3C is not reaching the acidic lumen of
lysosomes, suggesting that LC3C is conjugated to the outer
membrane of autophagosomes. Furthermore, lysosomal
TECPR1 selectively recruits LC3C vesicles based on a physical
interaction between both proteins. This interaction depends on
the canonical LIR W175AKI177 and the TR1 domain of TECPR1.
Finally, we show that TECPR1 promotes the fusion of LC3C
autophagosomes with lysosomes to promote degradation of
protein aggregates.
The fusion of autophagosomes and lysosomes requires a
complex molecular machinery that coordinates the specific
recruitment, tethering and fusion of both organelles. Not sur-
prisingly, many factors are known to coordinate this process
including the tethering factors EPG5, HOPS and
PLEKHM122,23,31 as well as SNARE proteins STX17, SNAP29
and VAMP832,33. In order to untangle TECPR1 functions from
the apparently complex interaction network of other lysosomal
proteins, we targeted TECPR1 to endosomal compartments by
exchanging its PH domain against a 2xFYVE domain. We found
that TECPR1ΔPH-2xFYVE reroutes LC3C from lysosomes to
endosomes, demonstrating that TECPR1 is a lysosomal recruit-
ment factor that acts independently and most upstream in a series
of events that leads to the fusion of LC3C autophagosomes with
lysosomes.
Moreover, we characterized the binding specificity and func-
tion of the PH domain of TECPR1 to reveal its contribution to
aggrephagy. We found that the PH domain selectively binds
PtdIns(4)P in vitro and is required to target TECPR1 to PtdIns(4)
P-positive lysosomes in vivo. This observation is significant
because increasing experimental evidence revealed that PtdIns(4)
P regulates fusion of autophagosomes and lysosomes20,34. Our
study revealed a yet unknown function of lysosomal PtdIns(4)P.
We showed that the PH domain recruits TECPR1 to a population
of lysosomes that contains PtdIns(4)P. Moreover, we found that
TECPR1 is preferentially recruited to autolysosomes, which fuse
with several LC3C autophagosomes. Collectively, these observa-
tions imply that a subpopulation of TECPR1 and PtdIns(4)P-
positive lysosomes represent specialized compartments to
degrade autophagic cargo.
Interestingly, an accumulation of TDP-43 aggregates in
frontotemporal dementia and amyotrophic lateral sclerosis
correlates with a significant downregulation of TECPR1
expression in neurons14,15. Moreover, autophagosomes accu-
mulate in neurons of patients who suffer from other neurode-
generative diseases including Huntington’s, Alzheimer’s and
Parkinson’s disease. This suggests that protein homeostasis in
neurons depends strongly on autophagy in general and
TECPR1 in particular. We found that overexpression of
TECPR1WT in NSCs facilitates clearance of protein aggregates
in an autophagy-dependent manner. Moreover, targeting
TECPR1 to endosomal compartments or inhibition of autop-
hagy leads to a strong accumulation of LC3C autophagosomes
and of HttQ97 inclusions. Correspondingly, an accumulation of
protein aggregates is also observed in NSC in which LC3C has
been depleted. The neuroprotective function of TECPR1 that
we discovered in our study implies that its augmented expres-
sion could potentially counteract the onset of neurodegenera-
tive diseases.
Methods
Reagents. The following synthetic lipids were purchased from Avanti Polar
Lipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoserine (POPS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE),
cholesterol, lissamine-rhodamine-PE, 1,2-dioleoyl-sn-glycero-3-phosphoinosi-
tol-3′-phosphate (PtdIns(3)P), 1,2-dioleoyl-sn-glycero-3-phosphoinositol-3′,5′-
bisphosphate (PtdIns(3,5)P2) and 1,2-dioleoyl-sn-glycero-3-phosphoinositol-4′-
phosphate (PtdIns(4)P). PI3-kinase inhibitor Wortmannin was purchased from
Sigma (W1628) and the VPS34-specific inhibitor SAR405 from Clinisciences
(A8883-1ml).
Antibodies. The following antibodies were used in this study: anti-HA (Santa
Cruz, sc-7392), anti-β-actin (Invitrogen, MA1-140), anti-LAMP2 (Santa
Cruz, sc-18822), anti-LAMP1 (CST, 9091), anti-LC3 (MBL International,
M152-3), anti-p62 (BD Biosciences, 610833), anti-STX17 (GeneTex,
GTX130212), anti-EEA1 (CST, 3288), anti-Rab5 (CST, 3547), anti-Rab7 (CST,
9367), anti-Rab11A (Invitrogen, 700184), anti-Ub (Enzo Life Sciences, BML-
PW8810), anti-Hsp60 (CST, 12165), anti-PMP70 (Sigma-Aldrich,
SAB4200181), anti-EGFR (Santa Cruz, sc-03-G), anti-PtdIns(4)P (Echelon, Z-
P004), anti-GFP (Invitrogen, A-6455), anti-myc (9E10, Biochemistry core
facility, MPI of Biochemistry, Martinsried), anti-PtdIns(4,5)P2 (Echelon, Z-
P045) and anti-HA (CST, 3724).
Plasmids. Full-length cDNAs encoding isoform 1 of human LC3A, LC3B, LC3C,
GABARAP, GABARAPL1, GABARAPL2, ATG3, ATG5, ATG7, ATG10, ATG12
and TECPR1, and HGS were amplified by PCR from cDNA libraries (imaGenes
GmbH). For recombinant expression of proteins, cDNAs were cloned into
pCoofy vectors28. For expression of GFP-tagged hATG8 proteins in mammalian
cells, cDNAs were inserted into pEGFP-C1 between BglII and KpnI restriction
sites. TECPR1 and the TECPR1 domains TR1 (aa 1–377) and TR2 (aa 722–1165)
were cloned into pEGFP-C1 between XhoI and HindIII restriction sites, resulting
in GFP-TECPR1, GFP-TR1 and GFP-TR2. The plasmid ptfLC3 encoding mRFP-
eGFP-LC3 was a gift from Tamotsu Yoshimori (Addgene plasmid # 21074). To
generate RFP-GFP-LC3C, LC3 was replaced by LC3C by inserting LC3C cDNA
into pTfLC3 between BglII and KpnI restriction sites. N-terminal HA-tagged
LC3 proteins were generated by cloning LC3A, LC3B and LC3C cDNAs together
with 3xHA separated by a AQCS(GA)6GPTENSS linker into pLPCX (Clontech)
between HindIII and NotI restriction sites. The plasmid pmRFP-C1 was gen-
erated by substitution of eGFP in pEGFP-C1 with mRFP from pTfLC3 using
NheI and BspEI/AgeI restriction enzymes. LC3C and TECPR1 constructs were
inserted into pmRFP-C1 to generate the N-terminal RFP-tagged proteins RFP-
LC3C and RFP-TECPR1. Deletion of the PH domain in TECPR1 (TECPR1ΔPH,
Δaa 611–717) was introduced by PCR linearization of GFP-TECPR1 or RFP-
TECPR1, followed by homologous recombination using RecAf (NEB).
TECPR1ΔPH-2xFYVE was generated by replacing the PH domain (aa 611–717) in
GFP-TECPR1 and RFP-TECPR1 by two repeats of the FYVE domain of HGS (aa
147–222) separated by a QGQGS linker. TECPR1 constructs (TECPR1wt,
TECPR1ΔPH, TECPR1ΔPH-2xFYVE) were cloned into pLPCX between HindIII
and NotI restriction sites. To construct the PtdIns(3)P-sensor RFP-2xFYVE, two
repeats of the FYVE domain of HGS (aa 147–222) separated by a QGQGS linker
were cloned into pmRFP-C1 between XhoI and BamHI restriction sites.
MycBioID-TECPR1 was cloned by amplification of BioID2 from MCS-BioID2-
HA, which was a gift from Kyle Roux (Addgene plasmid # 74224) and sub-
sequent insertion together with an N-terminal Myc-tag into TECPR1 in pLPCX
between XhoI and HindIII restriction sites. TECPR1 LIR mutants (W175A,
I178A, W175A/I178A) were generated using the QuikChange Lightning Site-
Directed Mutagenesis Kit (Agilent) according to the manufacturer’s instructions.
The plasmid pRC containing the aggregate prone variant HttQ97 was a gift from
F. Ulrich Hartl35.
Primers. Primers used for cloning of hATG8s. Gene-specific sequences are
black, restriction sites are marked in blue, homolog sequences to the linearized
vector are marked in green, and additionally added base pairs are indicated
in red.
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Primers used for cloning of TECPR1 and TECPR1 constructs. Gene-specific
sequences are black, restriction sites are marked in blue, homolog sequences to
either the linearized vector or the preceding ORF sequence are marked in green,
and additionally added or altered base pairs are marked in red.
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Primers used for cloning of RFP-2xFYVE. Gene-specific sequences are black,
homolog sequences to either the linearized vector or the preceding ORF sequence
are marked in green, and additionally added base pairs are marked in red.
Guide RNAs used for CRISPR/Cas9-mediated gene knockout of TECPR1 and
ATG16L1. Added BbsI restriction sites are indicated in blue and additionally
added G–C pairs are indicated in red.
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Expression and purification of proteins. ATG3 and the hATG8 proteins LC3A,
LC3B, LC3C, GABARAP, GABARAPL1 and GABARAPL2 were cloned into
pCoofy1, resulting in N-terminal His6-tagged proteins. hATG8 proteins were
expressed with a C-terminal deletion that reveals the reactive glycine and with an
N-terminal cysteine for fluorescent labeling. The ATG12–ATG5 conjugate was
produced by coexpressing ATG7, ATG10, ATG12 and ATG5 from the poly-
cystronic vector pST3936 with a His-tag fused to the N terminus of ATG12. The
TECPR1 peptide (TECPR1 158-187) and corresponding W175A/I178A LIR
mutant were cloned into pCoofy4 and expressed with N-terminal His6-MBP-tag.
ATG3, hATG8s, ATG12–ATG5 and TECPR1 peptides were expressed in E. coli
Rosetta. Cultures were grown in LB-medium and induced with 0.3 mM IPTG for
18 h at 18 °C. Cells were harvested and resuspended in lysing buffer (100 mM Tris-
HCl pH = 8.0, 300 mM NaCl, 20 mM imidazole, 10% glycerol) supplemented with
protease inhibitor cocktail (Sigma-Aldrich, P8849) as well as Benzonase (Sigma-
Aldrich). E. coli cells were lysed by sonication for 20 min at 4 °C (Sonopuls,
Bandelin). ATG7 was cloned into pCoofy27 to express N-terminal His6-tagged
protein and TECPR1 was cloned into pCoofy29, resulting in N-terminal His6-
MBP-tagged proteins. ATG7 was expressed in SF9 and TECPR1 in High Five insect
cells for 72 h at 25 °C37. Insect cells were harvested and resuspended in lysing
buffer supplemented with protease inhibitor cocktail as well as Benzonase. Insect
cells were lysed using a dounce homogenizer. Both E. coli and insect cell lysates
were centrifuged at 45,000×g for 1 h at 4 °C and the supernatant was incubated
with 1 ml Ni-NTA agarose (QIAGEN) for 1 h at 4 °C. Subsequently, the affinity
resin was washed and eluted with elution buffer (50 mM Tris-HCl pH = 7.4,
300 mM NaCl, 500 mM imidazole, 10% glycerol). The affinity tags were cleaved by
PreScission protease digest and digested proteins were subjected to size-exclusion
chromatography on a Superdex 75 (hATG8 proteins and ATG3) or Superdex
200 column (all others) using 25 mM Tris-HCl pH 7.4, 275 mM NaCl as running
buffer. TECPR1 peptides were directly subjected to a Superdex 200 column without
cleavage of the His6-MBP-tag. Fractions containing target protein were pooled,
concentrated, aliquoted, flash frozen in liquid nitrogen and stored at −80 °C
until use.
Fluorescent labeling of proteins. LC3C and TECPR1 were labeled by coupling
Alexa Fluor 488 C5 Maleimide (Molecular Probes) or CF®405M (Biotium) to the
introduced N-terminal cysteines or to native cysteines, respectively. Therefore,
proteins were mixed with fluorescent dye in a 1:1 ratio, incubated for 1 h at room
temperature, and unbound dye was removed using a HiTrap Desalting Column
(GE Healthcare).
Floatation assay. For generation of small unilamellar vesicles (SUVs), dried lipids
were dissolved in reaction buffer (12.5 mM Tris-HCl pH = 7.4, 137.5 mM NaCl,
0.1 mM DTT, 1 mM ATP/Mg2+), subjected to three freeze-thaw cycles and soni-
cated until the solution was clear. Lipid mixtures contained 59.9 mol% DOPC, 40
mol% DOPE, and 0.1 mol% lissamine-rhodamine-PE. Final protein stoichiometries
for lipidation reactions were ATG7:ATG3:hATG8:ATG12–ATG5, 1:1.5:6:0.5,
respectively. SUVs were incubated with the protein-mix in reaction buffer for 1 h at
37 °C. The protein/liposome mix was mixed with one volume 80% Histodenz in
floatation buffer (25 mM HEPES pH = 7.0, 100 mM NaCl) and overlaid with 30%
Histodenz and floatation buffer to generate a Histodenz step gradient (40%/30%/
0%). After ultracentrifugation at 165,000×g for 1 h, floated fractions containing
proteoliposomes (liposome fraction) and unbound proteins (protein fraction) were
analyzed by SDS-PAGE using NuPAGE 4–12% Bis-Tris gels (Novex).
PtdInsP binding assay. Giant unilamellar vesicles (GUVs) were prepared by
electroformation38 using lipid mixtures containing POPC (36.9 mol%), DOPE (30
mol%), cholesterol (20 mol%), POPS (10 mol%), PtdInsPs (3 mol%) and lissamine-
rhodamine-PE (0.1 mol%). PtdInsPs were protonated before incorporation into
GUVs. 100 µl GUVs were incubated with 100 µl of 1 µM TECPR1 in binding buffer
(25 mM Tris-HCl pH = 7.4, 275 mM NaCl, 0.2 mM DTT) for 30 min at 37 °C in an
observation chamber (Lab-Tek).
Cell culture and transfection. HeLa cells were purchased from Cell Lines Service
(# 300194). HeLa cells were cultured in DMEM (Gibco, 31966-021) supplemented
with 10% FBS (Sigma-Aldrich, F4135) and 1× Penicillin–Streptomycin (Gibco,
15140-122). Human neural stem cells (NSCs), derived from H9 (WA09) human
embryonic cell lines, were purchased from ThermoFisher scientific (# N7800).
NSCs were cultured in StemPro media (ThermoFisher Scientific) containing basic
fibroblast growth factor (FGF-2, 10 ng/ml) and Epidermal growth factor (EGF, 10
ng/ml). Culture plates and glass coverslips were coated with Geltrex (ThermoFisher
scientific, 12063569). HeLa cells and NSCs were cultured at 37 °C in a 5% CO2
incubator. HeLa cells were starved by washing them three times with DPBS and
incubation in Earle’s Balanced Salt Solution (EBSS; Sigma-Aldrich, E2888) for 2 h.
For lysotracker treatment, LysoTracker Deep Red (ThermoFisher Scientific) was
added to the cells in a concentration of 100 nM 30min prior to imaging. Formation
of protein aggregates was induced by treatment of cells with 5 µg/ml puromycin for
2 h. HeLa cells were transfected with TransIT-HeLaMONSTER® Transfection Kit
(Mirus, MIR2904) according to the manufacturer’s instructions and analyzed 24 h
post transfection. Transfection of NSCs was performed using the TransIT®-293
Transfection Reagent (Mirus, MIR2704) and samples were analyzed 24–36 h post
transfection. Autophagy was inhibited by treating cells with 400 nM of the
autophagy-inhibitor Bafilomycin A1 (Sigma-Aldrich, B1793) for 4 h. The PI3-
kinase was inhibited using wortmannin (SIGMA, W1628) at a final concentration
of 1.5 mM for 4 h or the VPS34-specific inhibitor SAR405 at a final concentration
of 10 µM for 2 h. Knockdowns of ATG8 variants was performed by incubating
HeLa cells or NSCs with Silencer siRNAs (Invitrogen, 4427037) at a final con-
centration of 10 nM for 48 h. Cotransfection with other plasmids was performed
24 h after addition of siRNAs and cells were incubated for another 24 h Table 1.
Generation of KO cell lines using CRISPR-Cas9. A HeLa KO cell line deficient
for TECPR1 was generated according to39. In brief, CRISPR guide RNAs that target
the first exon (Supplementary Table 1) were cloned into pSpCas9(BB)-2A-Puro
Table 1 siRNAs from Invitrogen.
siRNA Order number Sequence (5′–3′)
siControl Stealth RNAi CAACUUGAUCCGUCUGACGUGGAAU
siLC3A s39156
siLC3B s37748




siTECPR1 Stealth RNAi CCAGUUGGAUUGAGAUGGUUGGUGA
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(PX459), which was a gift from Feng Zhang (Addgene plasmid # 48139). Trans-
fected HeLa cells were selected with puromycin and clonal cell lines were isolated
by dilution. Genomic regions containing the editing site were amplified by PCR
and screened for frameshift mutations by sequencing.
BioID analysis. BioID34 was performed by cotransfecting HeLa TECPR1KO cells
with MycBioID-TECPR1, the corresponding W175A/I178A LIR mutant, or pLPCX
(mock) and HA-tagged hATG8s. 50 μM biotin was added at time of transfection
and cells were lysed 24 h post transfection. Lysates were incubated with Dynabeads
MyOne Streptavidin C1 (Invitrogen, 65001) overnight at 4 °C. Beads were washed
once with 2% SDS in 50 mM Tris-HCl pH = 7.4 and twice with BioID washing
buffer (50 mM Tris-HCl pH = 7.4, 500 mM NaCl, 1% Triton X-100, 1 mM EDTA).
Bound proteins were eluted in 2× SDS-PAGE sample buffer+ 3 mM biotin.
Samples were then blotted with anti-HA, anti-Myc and Streptavidin-HRP (Ther-
moScientific, 21130).
Immunocytochemistry. Cells grown on glass coverslips were fixed for 10 min with
4% formaldehyde, washed three times with PBS, permeabilized in permeabilization
solution (0.2% Triton X-100, 0.5% SDS, 4% BSA in PBS) for 5 min, washed three
times with PBS and incubated in blocking solution (4% BSA in PBS) for 1 h at
room temperature. Primary antibodies were diluted 1:100 in blocking solution and
incubated for 1 h at room temperature. After washing with PBS, samples were
incubated with Alexa Fluor secondary antibodies (Molecular Probes, dilution 1:500
in blocking solution) for 1 h at room temperature. Immunofluorescence with anti-
PtdIns(4)P, anti-LC3 and anti-Rab11A was performed according to the “Golgi
staining” protocol35. Immunofluorescence staining for PtdIns(4,5)P2 was per-
formed according to the manufacturer’s instructions. Coverslips were mounted on
slides with ProLong Gold antifade reagent (Invitrogen).
Immunoblotting. HeLa cells were lysed with mammalian lysis buffer (20 mM Tris
pH = 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100) supple-
mented with protease inhibitor cocktail (Sigma-Aldrich, P8340). Cell lysates were
subjected to SDS-PAGE, transferred to a PVDF membrane, and blotted with pri-
mary and secondary antibodies.
Confocal and superresolution microscopy. Confocal images were acquired on a
Leica TCS SP8 AOBS Confocal Laser Scanning Microscope (×63/1.4 NA objective
for GUVs and fixed cells and ×63/1.2 NA objective for live cell imaging) using the
Leica LAS AF SP8 software. Structured-Illumination Microscopy (SIM) was per-
formed on a Zeiss Elyra PS.1 microscope (×63/1.4 NA objective) using the Zeiss
ZEN 2 software with SR-SIM module.
Immuno-electron microscopy. Immuno-electron microscopy was performed by
cryosectioning and immunolabeling40. In brief, HeLa cells transiently expressing
GFP-TECPR1 were fixed in two steps, first with 8% paraformaldehyde (PFA) and
0.4% glutaraldehyde (GA) in PHEM buffer for 5 min at room temperature and
second with 4% PFA/0.2% GA in PHEM buffer for 30 min at room temperature.
Cells were embedded in 2% gelatin, infused with 2.3 M sucrose at 4 °C, mounted
onto pins and plunge-frozen in liquid nitrogen. Ultrathin cryosections were cut
using a Leica EM FC6 cryo-ultramicrotome. Sections were immunolabeled with
anti-GFP (1:50) and protein A conjugated to 10 nm gold. Samples were viewed on a
Philips CM120 BioTwin Transmission Electron Microscope.
Correlative light electron microscopy. For CLEM experiments, HeLa wt or
TECPR1KO cells were grown on carbon-coated sapphire discs and transfected with
fluorescently tagged proteins. Cells were cryofixed using a HPM-010 High Pressure
Freezing Machine (ABRA Fluid) and frozen samples were embedded in Lowicryl
HM20 using a Leica EM AFS2. Freeze substitution was performed at −90 °C for 11
h with 0.1% uranyl acetate in acetone. The temperature was then raised to −45 °C
at 5 °C/h and stayed at −45 °C for 5 h. Samples were washed three times with
acetone and infiltrated with increasing concentrations (10%, 25%, 50%, 75%, 4 h
each) of Lowicryl HM20 while the temperature was further increased to −25 °C.
100% Lowicryl HM20 was exchanged three times (10 h each) and UV polymerized
at −25 °C for 48 h, followed by raising the temperature to 20 °C at 5 °C/h. Sections
of 70 or 300 nm were cut on a Leica EM UC7 ultramicrotome and picked up on
carbon-coated mesh grids. TetraSpeck Microspheres (100 nm, Invitrogen) were
used as fiducial markers and adhered to the sections. Fluorescent microscopy
imaging was performed using a widefield Olympus IX81 microscope equipped with
an Olympus PlanApo ×100/1.40NA oil immersion objective41. Images were col-
lected with GFP- and Cy3-specific settings. Grids carrying 70 nm sections were
post-stained with 2% uranyl acetate and lead citrate and imaged on a Philips
CM120 BioTwin Transmission Electron Microscope. Grids with 300 nm sections
were incubated with protein A conjugated to 10 nm gold on both sides of the grid
as tomographic fiducial markers, followed by post-staining with 2% uranyl acetate
and lead citrate. Tomograms were collected on a TECNAI F30 Transmission
Electron Microscope (FEI company) as dual-axis tilt series over a −60° to 60° tilt
range with 1° increment and a magnification of ×9400 or ×15,500. A montage of
the whole cell was created with lower magnification to correlate the electron
micrograph with the fluorescent images using fiducial markers.
Image analysis. Confocal and superresolution images were analyzed using Fiji.
The number of GFP-hATG8 puncta was counted from Z-projections. Intensities of
Alexa Fluor 488 on GUVs were normalized to the intensity of InSpeck fluorescent
beads. Colocalization analysis was performed by calculating the Pearson’s corre-
lation coefficient of single cells using a custom-made script based on the Fiji plugin
Coloc2. EM tomograms were reconstructed using the IMOD software package. EM
and fluorescent images were correlated using the ec-CLEM plugin of the
software icy.
Proteinase K protection assay. GFP-LC3C transfected cells were harvested and
resuspended in homogenization buffer (HB: 20 mM Tris-HCl pH 8.0, 140 mM
NaCl, 250 mM sucrose, 1 mM EDTA) followed by mechanical lysis by passing the
suspension 15 times through a 27 gauge syringe. The nuclear fraction was sepa-
rated by centrifuging at 7700 × g for 5 min. The supernatant was subjected to
ultracentrifugation at 100,000 × g for 30 min. The corresponding pellet was
resuspended in HB buffer and incubated with Proteinase K at a final concentration
of 100 µg/ml in the presence or absence of Triton X-100 (0.5%) for the indicated
times. The reaction was stopped by addition of 1 mM phenylmehtylsulfonyl
fluoride and analyzed by immunoblotting.
Co-immunoprecipitation assays. HeLa cells expressing either GFP-TECPR1 or
GFP were transfected with plasmids containing HA-tagged variants of human
ATG8 proteins. Cells were harvested 24 h post transfection and resuspended in
lysis buffer (LB: 10 mM Hepes pH= 7.5, 0.22 M Mannitol, 0.07 M Sucrose,
PMSF 100 nM). Cells were lysed by passing the suspension 30 times trough a 27
gauge syringe. Cellular debris was removed by centrifugation at 2000 × g for 10
min. Supernatant was incubated with GFP Trap magnetic beads (CHROMO-
TEK, gtma-20) overnight at 4 °C. Beads were washed using washing buffer (WB:
10 mM Tris-HCl pH= 7.5, 150 mM NaCl, 0.5 mM EDTA) and resuspended in
2× SDS buffer. Samples were analyzed by immunoblotting using antibodies as
indicated.
Statistical analysis and reproduciblitiy. Data are expressed as mean ± standard
deviation (SD) of at least three independent experiments or at least 20 cells. Sta-
tistical parameters including statistical significance and n value are reported in the
Figs. or Fig. legends. Box plots were generated using the OriginPro 9.1G software
and bottom and top of the box represent the first (25%) and third (75%) quartiles,
respectively. For statistical comparison of two groups of samples, the two-tailed
unpaired t-test was used. P-values of < 0.05 were considered statistically significant
and are indicated as following: *P < 0.05; **P < 0.01; ***P < 0.001. The exact P-
values are given in the Source Data file.
All experiments shown are derived from two to three independent experiments
(Figs. 1a, d, 2c, d, 3b, c, 4a–d, 5c, 6b, c, 7b, Supplementary Figs. 1c, d, 3a–f, 6d–f, 7g,
k = three independent experiments; Figs. 2a, b, 6a, Supplementary Figs. 1e–g, 2a, c,
4a–c, e–g, 5a–f, 6a, b = two independent experiments, Supplementary Figs. 6c, 7b,
d = one experiment).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analyzed during this study are included in this published article
(and its Supplementary information files). Data sharing is not applicable to this article as
no datasets were generated or analyzed during the current study. The source data
underlaying Figs. 1a–c, 2c, d, 3a, 5b, d, e, 6d, 7d and Supplementary Figs. 1a, b, 2b, c, 4d,
5c, 6c, e, h, 7b, d, g, k are provided as a Source Data file. Source data are provided with
this paper.
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